1/8
08:42 am
dnli
Denali Therapeutics (NASDAQ:DNLI) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Denali Therapeutics (NASDAQ:DNLI) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
1/8
08:42 am
dnli
Denali Therapeutics (NASDAQ:DNLI) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Denali Therapeutics (NASDAQ:DNLI) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
1/7
03:39 pm
dnli
Rating for DNLI
Low
Report
Rating for DNLI
1/7
10:02 am
dnli
Denali Therapeutics (NASDAQ:DNLI) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Medium
Report
Denali Therapeutics (NASDAQ:DNLI) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
12/11
09:29 am
dnli
Rating for DNLI
Low
Report
Rating for DNLI
12/11
09:29 am
dnli
Rating for DNLI
Low
Report
Rating for DNLI
12/5
08:38 am
dnli
Rating for DNLI
Low
Report
Rating for DNLI
12/5
08:38 am
dnli
Rating for DNLI
Low
Report
Rating for DNLI
12/5
08:09 am
dnli
Denali Therapeutics (NASDAQ:DNLI) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $32.00 price target on the stock.
Low
Report
Denali Therapeutics (NASDAQ:DNLI) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $32.00 price target on the stock.
12/5
08:08 am
dnli
Denali Therapeutics (NASDAQ:DNLI) had its "outperform" rating reaffirmed by analysts at Wedbush.
Low
Report
Denali Therapeutics (NASDAQ:DNLI) had its "outperform" rating reaffirmed by analysts at Wedbush.
12/5
08:08 am
dnli
Denali Therapeutics (NASDAQ:DNLI) had its "outperform" rating reaffirmed by analysts at Wedbush.
Low
Report
Denali Therapeutics (NASDAQ:DNLI) had its "outperform" rating reaffirmed by analysts at Wedbush.
12/5
05:35 am
dnli
Rating for DNLI
Low
Report
Rating for DNLI
11/4
09:59 am
dnli
Rating for DNLI
Low
Report
Rating for DNLI